Your account is not claimed yet. You can sign up with ORCID to claim your account.

Simon James Harrison (Simon J Harrison, Simon Harrison)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 23

Top Venues

British journal of haematology

Blood cancer journal

Leukemia & lymphoma

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew Spencer, Anna Kalff, Jake Shortt, Hang Quach, Craig Wallington-Gates, John Reynolds, Patricia Walker, Simon James Harrison, Rosanne Dunn, Cameron Wellard
A sequential cohort study evaluating single-agent KappaMab and KappaMab combined with lenalidomide and low-dose dexamethasone in relapsed and/or refractory kappa light chain-restricted multiple myeloma (AMaRC 01-16). British journal of haematology (2023)
Deborah Meyran, Joe Jiang Zhu, Jeanne Butler, Daniela Tantalo, Sean MacDonald, Thu Ngoc Nguyen, Minyu Wang, Niko Thio, Criselle D'Souza, Vicky Mengfei Qin, Clare Y Slaney, Aaron Harrison, Kevin Sek, Pasquale Petrone, Kevin Thia, Lauren Giuffrida, Andrew Mark Scott, Rachael L Terry, Ben Tran, Jayesh Desai, Henry Miles Prince, Simon James Harrison, Paul A Beavis, Michael H Kershaw, Benjamin J Solomon, Paul G Ekert, Joseph A Trapani, Phillip K Darcy, Paul Joseph Neeson
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models. Science translational medicine 15 (690) (2023)
Beatrice Z Sim, Anthony Longhitano, Jeremy Er, Simon James Harrison, Monica A Slavin, Benjamin W Teh
Infectious complications of bispecific antibody therapy in patients with multiple myeloma. Blood cancer journal 13 (1) (2023)
Gemma Reynolds, Edward Robert Scheffer Cliff, Ghulam Rehman Mohyuddin, Rakesh Popat, Shonali Midha, Melissa Ng Liet Hing, Simon James Harrison, Aaron Kesselheim, Benjamin W Teh
Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis. Blood advances (2023)
Beatrice Z Sim, Anthony Longhitano, Jeremy Er, Simon James Harrison, Monica A Slavin, Benjamin W Teh
Infectious complications of bispecific antibody therapy in patients with multiple myeloma. Blood cancer journal 13 (1) (2023)
Simon Cheah, Julie K Bassett, Fiona J Bruinsma, John Hopper, Harindra Jayasekara, Doug Joshua, Robert J MacInnis, H Miles Prince, Melissa C Southey, Claire M Vajdic, Marina T van Leeuwen, Nicole Wong Doo, Simon James Harrison, Dallas R English, Graham G Giles, Roger L Milne
Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma. Expert review of hematology (2023)
Beatrice Z Sim, Anthony Longhitano, Jeremy Er, Simon James Harrison, Monica A Slavin, Benjamin W Teh
Infectious complications of bispecific antibody therapy in patients with multiple myeloma. Blood cancer journal 13 (1) (2023)
Beatrice Z Sim, Anthony Longhitano, Jeremy Er, Simon James Harrison, Monica A Slavin, Benjamin W Teh
Infectious complications of bispecific antibody therapy in patients with multiple myeloma. Blood cancer journal 13 (1) (2023)
Mika Casey, Cui Tu, Simon James Harrison, Kyohei Nakamura
Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA. Blood advances 6 (17) (2022)
Adam H Lapidus, Mary Ann Anderson, Simon James Harrison, Michael J Dickinson, Tomas Kalincik, Arian Lasocki
Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy. Leukemia & lymphoma 63 (10) (2022)
Joanne L C Tan, Cameron Wellard, Elizabeth M Moore, Peter Mollee, Rajeev Rajagopal, Hang Quach, Simon James Harrison, Emma-Jane McDonald, P Joy Ho, Henry Miles Prince, Bradley M Augustson, Philip Campbell, Zoe K McQuilten, Erica M Wood, Andrew Spencer, null null
The second revision of the International Staging System (R2-ISS) stratifies progression-free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population. British journal of haematology (2022)
Matthew J Rees, Ashish Panigrahi, Simon James Harrison, Andrew Spencer, Tiffany Khong, Simon Gibbs, Jay Hocking, Andrew Grigg, Daniela Zantomio
The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma. Bone marrow transplantation 57 (6) (2022)
Zoe K McQuilten, Cameron Wellard, Elizabeth M Moore, Bradley Augustson, Krystal Bergin, Hilary Blacklock, Simon James Harrison, P Joy Ho, Tracy King, Hang Quach, Peter Mollee, Brian Rosengarten, Patricia Walker, Erica Wood, Andrew Spencer, null null
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR). British journal of haematology 198 (5) (2022)
Sophie Beaumont, Simon James Harrison, Jeremy Er
Review of Myeloma Therapies and Their Potential for Oral and Maxillofacial Side Effects. Cancers 13 (17) (2021)
Jeremy Er, David Routledge, Jennifer Hempton, Colin Wood, Trish Joyce, Simon James Harrison, Philip Campbell
Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two-centre Australian experience. Internal medicine journal 51 (2) (2021)
Jeremy Er, Simon James Harrison
KRd: the new KiD in the French myeloma induction class. Blood 138 (2) (2021)
Lauren Giuffrida, Kevin Sek, Melissa A Henderson, Junyun Lai, Amanda X Y Chen, Deborah Meyran, Kirsten L Todd, Emma V Petley, Sherly Mardiana, Christina Mølck, Gregory D Stewart, Benjamin J Solomon, Ian A Parish, Paul Joseph Neeson, Simon James Harrison, Lev M Kats, Imran G House, Phillip K Darcy, Paul A Beavis
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy. Nature communications 12 (1) (2021)
Simon James Harrison, Aurore Perrot, Adrian Alegre, David Simpson, Ming Chung Wang, Andrew Spencer, Sosana Delimpasi, Cyrille Hulin, Kazutaka Sunami, Thierry Facon, Philip Vlummens, Kwee L Yong, Frank Campana, Marlène Inchauspé, Sandrine Macé, Marie-Laure Risse, Helgi van de Velde, Paul Gerard Richardson
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics. British journal of haematology 194 (1) (2021)
Krystal Bergin, Cameron Wellard, Bradley Augustson, Rachel Cooke, Hilary Blacklock, Simon James Harrison, Joy Ho, Tracy King, Hang Quach, Peter Mollee, Patricia Walker, Elizabeth M Moore, Zoe McQuilten, Erica Wood, Andrew Spencer, null null
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR). Bone marrow transplantation 56 (10) (2021)
Dawn Swan, David Routledge, Simon James Harrison
The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies. British journal of haematology (2021)
Amit Khot, Natalie Brajanovski, Donald P Cameron, Nadine Hein, Kylee H Maclachlan, Elaine Sanij, John Lim, John Soong, Emma Link, Piers Blombery, Ella R Thompson, Andrew Fellowes, Karen E Sheppard, Grant A McArthur, Richard B Pearson, Ross D Hannan, Gretchen Poortinga, Simon James Harrison
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study. Cancer discovery 9 (8) (2019)
Abby P Douglas, Karin A Thursky, Leon J Worth, Simon James Harrison, Rod John Hicks, Monica A Slavin
FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia. Leukemia & lymphoma 60 (10) (2019)
Nadine Hein, Donald P Cameron, Katherine M Hannan, Nhu-Y N Nguyen, Chun Yew Fong, Jirawas Sornkom, Meaghan Wall, Megan Pavy, Carleen Cullinane, Jeannine Diesch, Jennifer R Devlin, Amee J George, Elaine Sanij, Jaclyn Quin, Gretchen Poortinga, Inge Verbrugge, Adele Baker, Denis Drygin, Simon James Harrison, James D Rozario, Jason A Powell, Stuart M Pitson, Johannes Zuber, Ricky W Johnstone, Mark A Dawson, Mark A Guthridge, Andrew Wei, Grant A McArthur, Richard B Pearson, Ross D Hannan
Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood 129 (21) (2017)

Simon James Harrison.css-eqlu8i{font-size:small;padding-left:4px;} (Simon J Harrison, Simon Harrison)

Publication Activity (10 Years)

Top Topics

Top Venues

Simon James Harrison (Simon J Harrison, Simon Harrison)